Camron D. Bryant, PhD
Associate Professor
Boston University School of Medicine
Dept of Pharmacology & Experimental Therapeutics

PhD, University of California, Los Angeles

Pronouns: he/him/his



Dr. Bryant is the Director of the Laboratory of Addiction Genetics and Associate Professor of Pharmacology and Experimental Therapeutics and Psychiatry at Boston University School of Medicine. Substance abuse disorders are heritable psychiatric conditions whose genetic basis remains largely unknown. Mammalian model organisms offer a powerful, complementary tool for accelerating the discovery of novel genetic factors and neurobiological mechanisms in humans. The Laboratory of Addiction Genetics integrates classical forward genetics in mice with contemporary genome editing and transcriptome technologies to understanding the mechanisms that confer susceptibility versus resilience toward addiction. We are committed to the development of novel behavioral models across multiple abused substances that most directly gauge the contribution of natural genetic variation and bridging these discoveries with systems-level neurobiology and molecular genetics to validate candidate functional variants. This multi-pronged approach leverages our ability to make discoveries that could translate to new pharmacotherapeutic avenues for treatment and prevention.

Director, Laboratory of Addiction Genetics
Boston University School of Medicine


Associate Professor
Boston University School of Medicine
Psychiatry


Member
Boston University
Genome Science Institute


Graduate Faculty (Primary Mentor of Grad Students)
Boston University School of Medicine, Graduate Medical Sciences



2021 American College of Neuropsychopharmacology (ACNP): Elected Full Member
2021-2022 International Behavioural and Neural Genetics Society (IBANGS): President
2019 Boston University: Jack Spivack Award for Excellence in Neuroscience
2016 American College of Neuropsychopharmacology (ACNP): Elected Associate Member
2015 Boston University: Jack Spivack Excellence in Neurosciences Research Award
2014 International Behavioural and Neural Genetics Society (IBANGS): Young Scientist Award
2014 Winter Conference on Brain Research (WCBR): Junior Investigator Travel Fellowship
2013 World Congress of Psychiatric Genetics: Poster abstract selected for oral presentation
2013 International Behavioural and Neural Genetics Society (IBANGS): Outstanding Young Investigator Award for Junior Faculty
2012 International Behavioural and Neural Genetics Society (IBANGS): Travel Award
2011 American College of Neuropsychopharmacology (ACNP): Early Career Travel Award - Abstract selected for Breakout Session oral presentation
2011 NIDA: Travel Award for Miniconvention, “Frontiers in Addiction Research”
2011 International Behavioural and Neural Genetics Society (IBANGS): Travel Award
2011 International Narcotics Research Conference (INRC): Travel Award
2009 International Behavioural and Neural Genetics Society (IBANGS): Travel Award
2008 International Behavioural and Neural Genetics Society (IBANGS): Outstanding Young Investigator Award for Postdocs
2005 INRC: Travel Award
2002 INRC: Travel Award
2000 UCLA: Hatos Center for Neuropharmacology Training Fellowship
1999 UCLA: Achievement Rewards for College Scientists (ARCS) Scholarship
1998-1999 UIUC: Honors Program and thesis in the Department of Psychology


A Reduced Complexity Cross in BALB/c substrains to identify the genetic basis of oxycodone dependence phenotypes
09/01/2020 - 06/30/2025 (PI)
NIH/National Institute on Drug Abuse
5U01DA050243-02

Genetic Basis of Chemotherapy-Induced Neuropathy in a Reduced Complexity Cross
02/07/2018 - 01/31/2022 (Subcontract PI)
Virginia Commonwealth University NIH NCI
5R01CA221260-03

Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice
07/01/2015 - 06/30/2021 (PI)
NIH/National Institute on Drug Abuse
5R01DA039168-05

Overall NIDA Core "Center of Excellence" in Transcriptomics, Systems Genetics and the Addictome
08/01/2019 - 10/31/2020 (Subcontract PI)
The University of Tennessee on behalf of its Health Science Center NIH NIDA
5P30DA044223-03

Big Data Computational Methods for Analysis of Drugs of Abuse
09/01/2017 - 06/30/2020 (Subcontract PI)
The Leland Stanford Junior University NIH NIDA
5U01DA044399-03

Genetic basis of binge eating and its motivational components in a reduced complexity cross
09/15/2015 - 08/31/2018 (PI)
NIH/National Institute on Drug Abuse
5R21DA038738-02

Mapping G x E Interactions for Addiction Traits in a Reduced Complexity Cross
07/01/2014 - 06/30/2017 (PI)
NIH/National Institute on Drug Abuse
5R03DA038287-02

Bridging Genetic Variation with Behavior: Molecular and Functional Mechanisms.
05/01/2015 - 04/30/2017 (PI)
NIH/National Institute on Drug Abuse
3R00DA029635-05S2

Genetic Basis of Opioid Reward and Aversion in Mice
05/01/2013 - 04/30/2017 (PI)
NIH/National Institute on Drug Abuse
5R00DA029635-05S1



Title


Yr Title Project-Sub Proj Pubs
2021 A Reduced Complexity Cross in BALB/c substrains to identify the genetic basis of oxycodone dependence phenotypes 5U01DA050243-02
2021 Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross 5R01CA221260-04 2
2020 A Reduced Complexity Cross in BALB/c substrains to identify the genetic basis of oxycodone dependence phenotypes 1U01DA050243-01
2020 Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross 5R01CA221260-03 2
2019 Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross 5R01CA221260-02 2
2019 Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice 3R01DA039168-04S1 9
2019 Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice 5R01DA039168-05 9
2018 Genetic basis of chemotherapy-induced neuropathy in a reduced complexity cross 1R01CA221260-01A1 2
2018 Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice 3R01DA039168-03S2 9
2018 Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice 5R01DA039168-04 9
Showing 10 of 26 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Goldberg LR, Yao EJ, Kelliher JC, Reed ER, Wu Cox J, Parks C, Kirkpatrick SL, Beierle JA, Chen MM, Johnson WE, Homanics GE, Williams RW, Bryant CD, Mulligan MK. A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity. Genes Brain Behav. 2021 Nov; 20(8):e12774.View Related Profiles. PMID: 34677900
     
  2. Borrelli KN, Yao EJ, Yen WW, Phadke RA, Ruan QT, Chen MM, Kelliher JC, Langan CR, Scotellaro JL, Babbs RK, Beierle JC, Logan RW, Johnson WE, Wachman EM, Cruz-Martín A, Bryant CD. Sex Differences in Behavioral and Brainstem Transcriptomic Neuroadaptations following Neonatal Opioid Exposure in Outbred Mice. eNeuro. 2021 Sep-Oct; 8(5).View Related Profiles. PMID: 34479978; PMCID: PMC8454922; DOI: 10.1523/ENEURO.0143-21.2021;
     
  3. Kantak KM, Stots C, Mathieson E, Bryant CD. Spontaneously Hypertensive Rat substrains show differences in model traits for addiction risk and cocaine self-administration: Implications for a novel rat reduced complexity cross. Behav Brain Res. 2021 08 06; 411:113406.View Related Profiles. PMID: 34097899; PMCID: PMC8265396; DOI: 10.1016/j.bbr.2021.113406;
     
  4. Jimenez Chavez CL, Bryant CD, Munn-Chernoff MA, Szumlinski KK. Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains. Int J Mol Sci. 2021 May 21; 22(11). PMID: 34064099; PMCID: PMC8196757; DOI: 10.3390/ijms22115443;
     
  5. Yao EJ, Babbs RK, Kelliher JC, Luttik KP, Borrelli KN, Damaj MI, Mulligan MK, Bryant CD. Systems genetic analysis of binge-like eating in a C57BL/6J x DBA/2J-F2 cross. Genes Brain Behav. 2021 May 12; e12751.View Related Profiles. PMID: 33978997
     
  6. Borrelli KN, Langan CR, Dubinsky KR, Szumlinski KK, Carlezon WA, Chartoff EH, Bryant CD. Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice. Psychopharmacology (Berl). 2021 Jul; 238(7):2031-2041.View Related Profiles. PMID: 33758972
     
  7. Fultz EK, Coelho MA, Lieberman D, Jimenez-Chavez CL, Bryant CD, Szumlinski KK. Hnrnph1 is a novel regulator of alcohol reward. Drug Alcohol Depend. 2021 03 01; 220:108518. PMID: 33454624; PMCID: PMC7899125; DOI: 10.1016/j.drugalcdep.2021.108518;
     
  8. Bryant CD, Healy AF, Ruan QT, Coehlo MA, Lustig E, Yazdani N, Luttik KP, Tran T, Swancy I, Brewin LW, Chen MM, Szumlinski KK. Sex-dependent effects of an Hnrnph1 mutation on fentanyl addiction-relevant behaviors but not antinociception in mice. Genes Brain Behav. 2021 03; 20(3):e12711.View Related Profiles. PMID: 33145940
     
  9. Shab G, Fultz EK, Page A, Coelho MA, Brewin LW, Stailey N, Brown CN, Bryant CD, Kippin TE, Szumlinski KK. The motivational valence of methamphetamine relates inversely to subsequent methamphetamine self-administration in female C57BL/6J mice. Behav Brain Res. 2021 02 01; 398:112959. PMID: 33053382; PMCID: PMC7722188; DOI: 10.1016/j.bbr.2020.112959;
     
  10. Pourhaghighi R, Ash PEA, Phanse S, Goebels F, Hu LZM, Chen S, Zhang Y, Wierbowski SD, Boudeau S, Moutaoufik MT, Malty RH, Malolepsza E, Tsafou K, Nathan A, Cromar G, Guo H, Al Abdullatif A, Apicco DJ, Becker LA, Gitler AD, Pulst SM, Youssef A, Hekman R, Havugimana PC, White CA, Blum BC, Ratti A, Bryant CD, Parkinson J, Lage K, Babu M, Yu H, Bader GD, Wolozin B, Emili A. BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain. Cell Syst. 2020 Aug 26; 11(2):208.View Related Profiles. PMID: 32853540
     
Showing 10 of 52 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 52 publications over 16 distinct years, with a maximum of 11 publications in 2020

YearPublications
20033
20051
20062
20071
20082
20093
20112
20123
20143
20152
20164
20172
20182
20194
202011
20217

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:

72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Bryant's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department